This document provides guidance on access to unregistered medicines for animal use through the provisions of Section 21 of the Medicines and Related Substances Act, 1965.
The SAHPRA is mandated to regulate the quality, safety, and efficacy of all registered medicines. Prior to
registration of a medicine, access is limited to clinical trials authorized by the Authority and may in certain
circumstances, and in accordance with Section 21 of the Act, authorize the sale of an unregistered medicine for
such purposes and in such manner and during such period as the Authority may determine. Authorization of the
importation and use of unregistered medicines used in clinical trials is also covered by this document. However,
another set of guidelines that accompanies the use of unregistered medicines together with the protocol is provided as a separate document.